Neurobiology of addiction: a neurocircuitry analysis | Lancet Psychiatry,the | 2016 | 1.4K |
Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5) in veterans | Psychological Assessment | 2016 | 951 |
Estimating the true global burden of mental illness | Lancet Psychiatry,the | 2016 | 950 |
Measurement Invariance Conventions and Reporting: The State of the Art and Future Directions for Psychological Research | Developmental Review | 2016 | 911 |
Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Molecular Psychiatry | 2016 | 888 |
Understanding the burnout experience: recent research and its implications for psychiatry | World Psychiatry | 2016 | 825 |
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression | Molecular Psychiatry | 2016 | 797 |
Suicide prevention strategies revisited: 10-year systematic review | Lancet Psychiatry,the | 2016 | 773 |
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat | Journal of Psychiatric Research | 2016 | 736 |
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation | Biological Psychiatry | 2016 | 665 |
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial | Journal of Psychopharmacology | 2016 | 649 |
Exercise as a treatment for depression: A meta-analysis adjusting for publication bias | Journal of Psychiatric Research | 2016 | 646 |
Identifying the women at risk of antenatal anxiety and depression: A systematic review | Journal of Affective Disorders | 2016 | 600 |
Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group | Molecular Psychiatry | 2016 | 589 |
Alzheimer's disease: Targeting the Cholinergic System | Current Neuropharmacology | 2016 | 581 |
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study | Lancet Psychiatry,the | 2016 | 568 |
Conducting Clinical Research Using Crowdsourced Convenience Samples | Annual Review of Clinical Psychology | 2016 | 567 |
Scaling-up treatment of depression and anxiety: a global return on investment analysis | Lancet Psychiatry,the | 2016 | 548 |
Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α | Molecular Psychiatry | 2016 | 547 |
Assessment of the cortisol awakening response: Expert consensus guidelines | Psychoneuroendocrinology | 2016 | 546 |
Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States | Biological Psychiatry | 2016 | 538 |
Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories | Health Psychology Review | 2016 | 537 |
Suicide, Suicide Attempts, and Suicidal Ideation | Annual Review of Clinical Psychology | 2016 | 531 |
Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis | General Hospital Psychiatry | 2016 | 526 |
Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium | Molecular Psychiatry | 2016 | 525 |